SUBSCRIBE TO TMCnet
TMCnet - World's Largest Communications and Technology Community

TMCNet:  Research and Markets: Roche, Hologic, Qiagen, Becton Dickinson and Abbott Estimated to Have Earned 60% of Revenues in the 5.5 Billion Molecular Diagnostics Market in 2013

[March 31, 2014]

Research and Markets: Roche, Hologic, Qiagen, Becton Dickinson and Abbott Estimated to Have Earned 60% of Revenues in the 5.5 Billion Molecular Diagnostics Market in 2013

DUBLIN --(Business Wire)--

Research and Markets (http://www.researchandmarkets.com/research/h7699f/the_worldwide) has announced the addition of the "The Worldwide Market for Molecular Diagnostics - 6-Month Update" report to their offering.

Molecular diagnostics is becoming a dominant platform in clinical medicine and represents one of the fastest-growing segments of the diagnostics market.

Many molecular tests are CE Marked and FDA-cleared and many more are in development. However many more unique tests have been launched as test services, especially for cancer management and infectious disease epidemiology.

The report provides breakout of key market segments for molecular diagnostic markets i world regions, including developed nations and emerging nations.


It is expected that top-tier companies will continue to dominate due to their global reach and multi-segment participation. Further, as IVD markets in N. America and Europe offer little growth opportunities for the vast number of tests, the top tier has invested in molecular and personalized medicine testing and also has reinforced international connections. The report notes that while the names of the players dominating molecular testing have not changed extensively in recent years, their revenue growth rates have. High growth has shifted to innovators, while leaders are seeing flatter revenues.

The report indicates that IVD veterans Becton Dickinson, Gen-Probe (now part of Hologic), Abbott Diagnostics and Siemens (News - Alert) Healthcare hold their own in a highly competitive environment, while newcomers Meridian Biosciences and GenMark have made gains with user-friendly infectious disease tests. Meanwhile Pharma specialist Novartis has bailed out of the blood screening business to concentrate on other business units.

Companies Mentioned:

- Abbott

- Becton Dickinson

- Hologic

- Qiagen

- Roche

For more information visit http://www.researchandmarkets.com/research/h7699f/the_worldwide

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


[ Back To Technology News's Homepage ]

OTHER NEWS PROVIDERS







Technology Marketing Corporation

800 Connecticut Ave, 1st Floor East, Norwalk, CT 06854 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments: tmc@tmcnet.com.
Comments about this site: webmaster@tmcnet.com.

STAY CURRENT YOUR WAY

© 2014 Technology Marketing Corporation. All rights reserved.